The Cell-cell Adhesion Receptor Mel-CAM Acts As a Tumor Suppressor in Breast Carcinoma
Overview
Authors
Affiliations
Mel-CAM (MUC18 or CD146) is a cell adhesion molecule sharing sequence homology with members of the immunoglobulin gene superfamily. Mel-CAM was originally described as a marker associated with invasion and metastasis in melanoma. We determined here the distribution and biological significance of Mel-CAM in normal, benign proliferative, and neoplastic breast ductal epithelium. Using a Mel-CAM-specific monoclonal antibody, we, immunohistochemically demonstrate Mel-CAM expression in 14 of 14 (100%) normal breast epithelia and benign proliferative ductal epithelial lesions, whereas Mel-CAM expression can only be focally detected in 12 of 72 (17%) breast carcinomas. Solid-phase cell adhesion assay revealed that breast carcinoma cells in culture express the ligand for Mel-CAM. Transfection of Mel-CAM cDNA into breast carcinoma cells induces a more cohesive cell growth pattern and establishes smaller tumors in immunocompromised mice than mock transfectants. In conclusion, Mel-CAM is distributed throughout normal and benign proliferative mammary ductal epithelium, but it is frequently lost in carcinomas; it functions as a heterophilic cell-cell adhesion molecule in breast epithelium, and loss of Mel-CAM expression in breast carcinoma may be an important step for tumor progression.
Balcioglu O, Gates B, Freeman D, Hagos B, Mehrabad E, Ayala-Talavera D NPJ Breast Cancer. 2024; 10(1):80.
PMID: 39277578 PMC: 11401886. DOI: 10.1038/s41523-024-00687-7.
Gray G, Girnius N, Kuiken H, Henstridge A, Brugge J Cell Rep. 2023; 42(10):113293.
PMID: 37858468 PMC: 10840493. DOI: 10.1016/j.celrep.2023.113293.
Mannion A, Odell A, Baker S, Matthews L, Jones P, Cook G Front Cell Dev Biol. 2023; 11:1129015.
PMID: 37138793 PMC: 10150653. DOI: 10.3389/fcell.2023.1129015.
Sharma A, Joshkon A, Ladjimi A, Traboulsi W, Bachelier R, Robert S Int J Mol Sci. 2022; 23(2).
PMID: 35055160 PMC: 8780963. DOI: 10.3390/ijms23020974.
Role of Biomarkers in the Integrated Management of Melanoma.
Naik P Dis Markers. 2022; 2021:6238317.
PMID: 35003391 PMC: 8739586. DOI: 10.1155/2021/6238317.